Microneedle drug delivery systems usually include hollow microneedle and solid microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.

Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.

According to this study, over the next five years the Microneedle Drug Delivery Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Microneedle Drug Delivery Systems business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Microneedle Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.

This study considers the Microneedle Drug Delivery Systems value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Hollow Microneedle Technology

Solid Microneedle Technology

Dissolving Microneedles Technology

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Drug Delivery

Vaccine Delivery

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

3M

Zosano Pharma

Becton-Dickinson（BD）Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect, Inc

Vaxxas

Lohmann Therapie-Systeme AG

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Microneedle Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Microneedle Drug Delivery Systems market by identifying its various subsegments.

Focuses on the key global Microneedle Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Microneedle Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Microneedle Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Microneedle Drug Delivery Systems Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Microneedle Drug Delivery Systems Consumption 2014-2024

2.1.2 Microneedle Drug Delivery Systems Consumption CAGR by Region

2.2 Microneedle Drug Delivery Systems Segment by Type

2.2.1 Hollow Microneedle Technology

2.2.2 Solid Microneedle Technology

2.2.3 Dissolving Microneedles Technology

2.3 Microneedle Drug Delivery Systems Consumption by Type

2.3.1 Global Microneedle Drug Delivery Systems Consumption Market Share by Type (2014-2019)

2.3.2 Global Microneedle Drug Delivery Systems Revenue and Market Share by Type (2014-2019)

2.3.3 Global Microneedle Drug Delivery Systems Sale Price by Type (2014-2019)

2.4 Microneedle Drug Delivery Systems Segment by Application

2.4.1 Drug Delivery

2.4.2 Vaccine Delivery

2.4.3 Other

2.5 Microneedle Drug Delivery Systems Consumption by Application

2.5.1 Global Microneedle Drug Delivery Systems Consumption Market Share by Application (2014-2019)

2.5.2 Global Microneedle Drug Delivery Systems Value and Market Share by Application (2014-2019)

2.5.3 Global Microneedle Drug Delivery Systems Sale Price by Application (2014-2019)

3 Global Microneedle Drug Delivery Systems by Players

3.1 Global Microneedle Drug Delivery Systems Sales Market Share by Players

3.1.1 Global Microneedle Drug Delivery Systems Sales by Players (2017-2019)

3.1.2 Global Microneedle Drug Delivery Systems Sales Market Share by Players (2017-2019)

3.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players

3.2.1 Global Microneedle Drug Delivery Systems Revenue by Players (2017-2019)

3.2.2 Global Microneedle Drug Delivery Systems Revenue Market Share by Players (2017-2019)

3.3 Global Microneedle Drug Delivery Systems Sale Price by Players

3.4 Global Microneedle Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Microneedle Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Microneedle Drug Delivery Systems Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Microneedle Drug Delivery Systems by Regions

4.1 Microneedle Drug Delivery Systems by Regions

4.1.1 Global Microneedle Drug Delivery Systems Consumption by Regions

4.1.2 Global Microneedle Drug Delivery Systems Value by Regions

4.2 Americas Microneedle Drug Delivery Systems Consumption Growth

4.3 APAC Microneedle Drug Delivery Systems Consumption Growth

4.4 Europe Microneedle Drug Delivery Systems Consumption Growth

4.5 Middle East & Africa Microneedle Drug Delivery Systems Consumption Growth

5 Americas

5.1 Americas Microneedle Drug Delivery Systems Consumption by Countries

5.1.1 Americas Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)

5.1.2 Americas Microneedle Drug Delivery Systems Value by Countries (2014-2019)

5.2 Americas Microneedle Drug Delivery Systems Consumption by Type

5.3 Americas Microneedle Drug Delivery Systems Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Microneedle Drug Delivery Systems Consumption by Countries

6.1.1 APAC Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)

6.1.2 APAC Microneedle Drug Delivery Systems Value by Countries (2014-2019)

6.2 APAC Microneedle Drug Delivery Systems Consumption by Type

6.3 APAC Microneedle Drug Delivery Systems Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Microneedle Drug Delivery Systems by Countries

7.1.1 Europe Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)

7.1.2 Europe Microneedle Drug Delivery Systems Value by Countries (2014-2019)

7.2 Europe Microneedle Drug Delivery Systems Consumption by Type

7.3 Europe Microneedle Drug Delivery Systems Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Microneedle Drug Delivery Systems by Countries

8.1.1 Middle East & Africa Microneedle Drug Delivery Systems Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Microneedle Drug Delivery Systems Value by Countries (2014-2019)

8.2 Middle East & Africa Microneedle Drug Delivery Systems Consumption by Type

8.3 Middle East & Africa Microneedle Drug Delivery Systems Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Microneedle Drug Delivery Systems Distributors

10.3 Microneedle Drug Delivery Systems Customer

11 Global Microneedle Drug Delivery Systems Market Forecast

11.1 Global Microneedle Drug Delivery Systems Consumption Forecast (2019-2024)

11.2 Global Microneedle Drug Delivery Systems Forecast by Regions

11.2.1 Global Microneedle Drug Delivery Systems Forecast by Regions (2019-2024)

11.2.2 Global Microneedle Drug Delivery Systems Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Microneedle Drug Delivery Systems Forecast by Type

11.8 Global Microneedle Drug Delivery Systems Forecast by Application

12 Key Players Analysis

12.1 3M

12.1.1 Company Details

12.1.2 Microneedle Drug Delivery Systems Product Offered

12.1.3 3M Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 3M News

12.2 Zosano Pharma

12.2.1 Company Details

12.2.2 Microneedle Drug Delivery Systems Product Offered

12.2.3 Zosano Pharma Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Zosano Pharma News

12.3 Becton-Dickinson（BD）Technologies

12.3.1 Company Details

12.3.2 Microneedle Drug Delivery Systems Product Offered

12.3.3 Becton-Dickinson（BD）Technologies Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Becton-Dickinson（BD）Technologies News

12.4 Nanopass Technologies

12.4.1 Company Details

12.4.2 Microneedle Drug Delivery Systems Product Offered

12.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Nanopass Technologies News

12.5 Corium

12.5.1 Company Details

12.5.2 Microneedle Drug Delivery Systems Product Offered

12.5.3 Corium Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Corium News

12.6 Valeritas

12.6.1 Company Details

12.6.2 Microneedle Drug Delivery Systems Product Offered

12.6.3 Valeritas Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Valeritas News

12.7 Nitto

12.7.1 Company Details

12.7.2 Microneedle Drug Delivery Systems Product Offered

12.7.3 Nitto Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Nitto News

12.8 Microdermics

12.8.1 Company Details

12.8.2 Microneedle Drug Delivery Systems Product Offered

12.8.3 Microdermics Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Microdermics News

12.9 TheraJect, Inc

12.9.1 Company Details

12.9.2 Microneedle Drug Delivery Systems Product Offered

12.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 TheraJect, Inc News

12.10 Vaxxas

12.10.1 Company Details

12.10.2 Microneedle Drug Delivery Systems Product Offered

12.10.3 Vaxxas Microneedle Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Vaxxas News

12.11 Lohmann Therapie-Systeme AG

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Microneedle Drug Delivery Systems

Table Product Specifications of Microneedle Drug Delivery Systems

Figure Microneedle Drug Delivery Systems R